{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T02:27:26Z","timestamp":1790908046149,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,2,1]],"date-time":"2006-02-01T00:00:00Z","timestamp":1138752000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Cell Research"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1016\/j.yexcr.2005.10.026","type":"journal-article","created":{"date-parts":[[2005,12,15]],"date-time":"2005-12-15T12:59:32Z","timestamp":1134651572000},"page":"256-265","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells"],"prefix":"10.1016","volume":"312","author":[{"given":"Takanori","family":"Watanabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Hioki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiya","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiko","family":"Nishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Kagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Taki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikatsu","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriaki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyoshi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yexcr.2005.10.026_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S1470-2045(01)00618-0","article-title":"Oncolytic biotherapy: a novel therapeutic platform","volume":"3","author":"Hawkins","year":"2002","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.yexcr.2005.10.026_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1038\/nrc948","article-title":"Oncolytic viruses","volume":"2","author":"Chiocca","year":"2002","journal-title":"Nat. Rev., Cancer"},{"key":"10.1016\/j.yexcr.2005.10.026_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1200\/JCO.2001.19.2.289","article-title":"Phase II trial of intratumoral administration of ONYX-015, a replication-selective adenovirus, in patients with refractory head and neck cancer","volume":"19","author":"Nemunaitis","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2005.10.026_bib4","first-page":"7464","article-title":"A phase I trial of CV706, a replication-competent, PSA selective oncolytic adenovirus, for the treatment of locally recurrent prostate cancer following radiation therapy","volume":"61","author":"DeWeese","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib5","first-page":"6070","article-title":"Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints","volume":"62","author":"Reid","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib6","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1200\/JCO.2003.09.114","article-title":"Phase II trial of intravenous CI-1042 in patients with metastatic colorectal cancer","volume":"21","author":"Hamid","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.yexcr.2005.10.026_bib7","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1158\/1078-0432.CCR-1075-3","article-title":"Telomerase-specific replication-selective virotherapy for human cancer","volume":"10","author":"Kawashima","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib8","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1126\/science.275.5304.1320","article-title":"Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5","volume":"275","author":"Bergelson","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.yexcr.2005.10.026_bib9","doi-asserted-by":"crossref","first-page":"3352","DOI":"10.1073\/pnas.94.7.3352","article-title":"HCAR and MCAR: the human and mouse cellular receptors for subgroup C adenoviruses and group B coxsackieviruses","volume":"94","author":"Tomko","year":"1997","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.yexcr.2005.10.026_bib10","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1038\/sj.onc.1208460","article-title":"Enhanced oncolysis by a tropism-modified telomerase-specific replication-selective adenoviral agent OBP-405 (\u2018Telomelysin-RGD\u2019)","volume":"24","author":"Taki","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.yexcr.2005.10.026_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1038\/sj.cgt.7700440","article-title":"Enhanced antitumor effect and reduced vector dissemination with fiber-modified adenovirus vectors expressing herpes simplex virus thymidine kinase","volume":"9","author":"Mizuguchi","year":"2002","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2005.10.026_bib12","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/sj.cgt.7700806","article-title":"Complex mosaicism is a novel approach to infectivity enhancement of adenovirus type 5-based vectors","volume":"12","author":"Borovjagin","year":"2005","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.yexcr.2005.10.026_bib13","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7164\/antibiotics.47.301","article-title":"FR901228, a novel antitumor bicyclic depsipeptide produced by Chromobacterium violaceum No. 968: I. Taxonomy, fermentation, isolation, physico-chemical and biological properties, and antitumor activity","volume":"47","author":"Ueda","year":"1994","journal-title":"J. Antibiot. (Tokyo)"},{"key":"10.1016\/j.yexcr.2005.10.026_bib14","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1006\/excr.1998.4027","article-title":"FR901228, a potent antitumor antibiotic, is a novel histone deacetylase inhibitor","volume":"241","author":"Nakajima","year":"1998","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib15","first-page":"4916","article-title":"FK228 (depsipeptide) as a natural prodrug that inhibits class I histone deacetylases","volume":"62","author":"Furumai","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib16","first-page":"6230","article-title":"Enhanced adenovirus transgene expression in malignant cells treated with the histone deacetylase inhibitor FR901228","volume":"61","author":"Kitazono","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib17","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1182\/blood.V99.6.2248","article-title":"Histone deacetylase inhibitor FR901228 enhances adenovirus infection of hematopoietic cells","volume":"99","author":"Kitazono","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.10.026_bib18","first-page":"5394","article-title":"The histone deacetylase inhibitor FK228 preferentially enhances adenovirus transgene expression in malignant cells","volume":"9","author":"Goldsmit","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib19","first-page":"8680","article-title":"Epigenetic regulation of coxsackie and adenovirus receptor (CAR) gene promoter in urogenital cancer cells","volume":"63","author":"Pong","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib20","first-page":"847","article-title":"Modulation of coxsackie-adenovirus receptor expression for increased adenoviral transgene expression","volume":"63","author":"Hemminki","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib21","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1124\/jpet.105.083956","article-title":"Chemoresistance to depsipeptide FK228 [(E)-(1S,4S,10S,21R)-7-[(Z)-ethylidene]-4,21-diisopropyl-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8,7,6]-tricos-16-ene-3,6,9,22-pentanone] is mediated by reversible MDR1 induction in human cancer cell lines","volume":"314","author":"Xiao","year":"2005","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.yexcr.2005.10.026_bib22","doi-asserted-by":"crossref","first-page":"12243","DOI":"10.1128\/JVI.78.22.12243-12251.2004","article-title":"Conditionally replicating adenoviruses kill tumor cells via a basic apoptotic machinery-independent mechanism that resembles necrosis-like programmed cell death","volume":"78","author":"Abou","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.yexcr.2005.10.026_bib23","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1038\/nm0697-639","article-title":"ONYX-015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents","volume":"3","author":"Heise","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.yexcr.2005.10.026_bib24","first-page":"517","article-title":"Antitumor synergy of CV787, a prostate cancer-specific adenovirus, and paclitaxel and docetaxel","volume":"61","author":"Yu","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib25","first-page":"3743","article-title":"Identification of human uroplakin II promoter and its use in the construction of CG8840, a urothelium-specific adenovirus variant that eliminates established bladder tumors in combination with docetaxel","volume":"62","author":"Zhang","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib26","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0092-8674(02)00654-2","article-title":"Cooperation between complexes that regulate chromatin structure and transcription","volume":"108","author":"Narlikar","year":"2002","journal-title":"Cell"},{"key":"10.1016\/j.yexcr.2005.10.026_bib27","first-page":"2088","article-title":"Inhibition of the Raf\/MEK\/ERK pathway up-regulates expression of the coxsackievirus and adenovirus receptor in cancer cells","volume":"63","author":"Anders","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib28","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1006\/mthe.2000.0074","article-title":"Amplification of transgene expression in vitro and in vivo using a novel inhibitor of histone deacetylase","volume":"1","author":"Yamano","year":"2000","journal-title":"Mol. Ther."},{"key":"10.1016\/j.yexcr.2005.10.026_bib29","first-page":"2887","article-title":"Synergistic inhibition of human lung cancer cell growth by adenovirus-mediated wild-type p53 gene transfer in combination with docetaxel and radiation therapeutics in vitro and in vivo","volume":"7","author":"Nishizaki","year":"2001","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib30","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1046\/j.1359-4117.2002.01039.x","article-title":"A phase I trial of depsipeptide (FR901228) in patients with advanced cancer","volume":"2","author":"Marshall","year":"2002","journal-title":"J. Exp. Ther. Oncol."},{"key":"10.1016\/j.yexcr.2005.10.026_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1182\/blood-2004-05-1693","article-title":"A phase 1 and pharmacodynamic study of depsipeptide (FK228) in chronic lymphocytic leukemia and acute myeloid leukemia","volume":"105","author":"Byrd","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.yexcr.2005.10.026_bib32","doi-asserted-by":"crossref","first-page":"6259","DOI":"10.1158\/0008-5472.CAN-04-1335","article-title":"Visualization of intrathoracically disseminated solid tumors in mice with optical imaging by telomerase-specific amplification of a transferred green fluorescent protein gene","volume":"64","author":"Umeoka","year":"2004","journal-title":"Cancer Res."},{"key":"10.1016\/j.yexcr.2005.10.026_bib33","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1349-7006.2004.tb03232.x","article-title":"Late resistance to adenoviral p53-mediated apoptosis caused by decreased expression of Coxsackie-adenovirus receptors in human lung cancer cells","volume":"95","author":"Tango","year":"2004","journal-title":"Cancer Sci."},{"key":"10.1016\/j.yexcr.2005.10.026_bib34","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/0042-6822(68)90121-9","article-title":"The polypeptides of adenovirus: I. Evidence for multiple protein components in the virion and a comparison of types 2, 7A, and 12","volume":"36","author":"Maizel","year":"1968","journal-title":"Virology"},{"key":"10.1016\/j.yexcr.2005.10.026_bib35","doi-asserted-by":"crossref","first-page":"157","DOI":"10.7883\/yoken1952.47.157","article-title":"A simple and efficient method for purification of infectious recombinant adenovirus","volume":"47","author":"Kanegae","year":"1994","journal-title":"Jpn. J. Med. Sci. Biol."}],"container-title":["Experimental Cell Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482705004829?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014482705004829?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T03:47:39Z","timestamp":1757994459000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014482705004829"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,2]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["S0014482705004829"],"URL":"https:\/\/doi.org\/10.1016\/j.yexcr.2005.10.026","relation":{},"ISSN":["0014-4827"],"issn-type":[{"value":"0014-4827","type":"print"}],"subject":[],"published":{"date-parts":[[2006,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Histone deacetylase inhibitor FR901228 enhances the antitumor effect of telomerase-specific replication-selective adenoviral agent OBP-301 in human lung cancer cells","name":"articletitle","label":"Article Title"},{"value":"Experimental Cell Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yexcr.2005.10.026","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}